The emerging therapy of the medication represents a major advance in the handling of diabetes mellitus type 2. Different to existing medications, tirzepatide targets two pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide819658.xzblogs.com/82367975/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment